Shree Ganesh Biotech India Ltd
₹ 1.04
0.00%
22 Nov
- close price
About
Incorporated in 1982, Shree Ganesh Biotech Ltd is in the trading of seeds and bhushi
Key Points
- Market Cap ₹ 41.5 Cr.
- Current Price ₹ 1.04
- High / Low ₹ 1.89 / 0.86
- Stock P/E 34.8
- Book Value ₹ 1.59
- Dividend Yield 0.00 %
- ROCE 1.37 %
- ROE 0.99 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Stock is trading at 0.65 times its book value
- Debtor days have improved from 131 to 59.4 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.84% over last 3 years.
- Earnings include an other income of Rs.1.73 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.57 | 2.26 | 1.68 | 2.12 | 8.54 | 7.86 | 5.87 | 2.47 | 17.21 | 72.64 | 62.45 | 20.28 | 13.44 | |
1.07 | 1.84 | 1.17 | 1.47 | 4.78 | 4.36 | 4.08 | 2.23 | 16.50 | 69.19 | 60.30 | 20.48 | 13.98 | |
Operating Profit | 0.50 | 0.42 | 0.51 | 0.65 | 3.76 | 3.50 | 1.79 | 0.24 | 0.71 | 3.45 | 2.15 | -0.20 | -0.54 |
OPM % | 31.85% | 18.58% | 30.36% | 30.66% | 44.03% | 44.53% | 30.49% | 9.72% | 4.13% | 4.75% | 3.44% | -0.99% | -4.02% |
0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | -0.28 | 0.05 | 0.56 | 1.06 | 1.73 | |
Interest | 0.01 | 0.04 | 0.07 | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.08 | 0.21 | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.41 | 0.17 | 0.34 | 0.55 | 3.73 | 3.50 | 1.79 | 0.24 | 0.43 | 3.50 | 2.71 | 0.86 | 1.19 |
Tax % | 0.00% | 0.00% | 0.00% | 1.82% | 0.00% | 0.00% | 0.00% | 0.00% | 25.58% | 27.71% | 25.09% | 26.74% | |
0.41 | 0.17 | 0.34 | 0.54 | 3.73 | 3.50 | 1.79 | 0.24 | 0.32 | 2.53 | 2.04 | 0.62 | 1.19 | |
EPS in Rs | 0.11 | 0.05 | 0.09 | 0.15 | 1.01 | 0.95 | 0.04 | 0.01 | 0.01 | 0.06 | 0.05 | 0.02 | 0.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 28% |
3 Years: | 6% |
TTM: | -59% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | -19% |
3 Years: | 5% |
TTM: | 98% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -31% |
3 Years: | -48% |
1 Year: | 18% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 2% |
3 Years: | 3% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 19.93 | 19.93 | 19.93 | 19.93 | 39.86 | 39.86 | 39.86 |
Reserves | 1.89 | 2.06 | 2.41 | 2.94 | 6.68 | 10.18 | 37.31 | 37.54 | 37.86 | 40.39 | 22.49 | 23.12 | 23.68 |
0.18 | 0.33 | 0.61 | 0.50 | 0.06 | 0.19 | 0.19 | 0.19 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.45 | 0.08 | 0.12 | 0.03 | 10.87 | 14.16 | 6.66 | 7.06 | 16.64 | 33.24 | 17.18 | 10.64 | 0.12 | |
Total Liabilities | 4.35 | 4.30 | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.66 |
2.26 | 2.38 | 2.40 | 2.32 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.21 | 0.21 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 3.06 | 3.22 | 0.00 | 0.00 | 0.00 |
1.88 | 1.71 | 2.36 | 2.77 | 19.44 | 26.36 | 64.08 | 64.72 | 71.56 | 90.34 | 79.53 | 73.62 | 63.66 | |
Total Assets | 4.35 | 4.30 | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.66 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.22 | 0.19 | -0.07 | -0.04 | -12.94 | 2.23 | -0.50 | -1.01 | 2.36 | 3.57 | 10.54 | 10.16 | |
-0.39 | -0.33 | -0.11 | 0.00 | 2.53 | -2.36 | -32.07 | 0.99 | -2.36 | -3.37 | -10.09 | -10.21 | |
0.18 | 0.14 | 0.28 | -0.11 | 10.42 | 0.13 | 32.58 | 0.00 | 0.00 | -0.19 | 0.00 | 0.00 | |
Net Cash Flow | 0.01 | 0.00 | 0.10 | -0.16 | 0.02 | 0.00 | 0.01 | -0.02 | 0.01 | 0.01 | 0.44 | -0.05 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 34.87 | 92.06 | 260.71 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 | 59.39 |
Inventory Days | 975.33 | 298.37 | 483.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Payable | 263.28 | 20.28 | 46.27 | |||||||||
Cash Conversion Cycle | 746.92 | 370.15 | 697.69 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 | 59.39 |
Working Capital Days | 278.98 | 251.95 | 443.21 | 466.58 | 383.81 | 475.99 | 779.12 | 2,036.32 | 249.20 | 53.71 | 12.80 | -132.11 |
ROCE % | 11.63% | 5.17% | 9.04% | 12.25% | 54.34% | 33.70% | 5.14% | 0.42% | 1.23% | 5.92% | 4.42% | 1.37% |
Documents
Announcements
-
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
23 Oct - Disclosure of fund utilization status as per SEBI regulations.
- Regulations 30, 33 And Other Applicable Provisions Of The SEBI (LODR) Regulations, 2015 23 Oct
-
Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.
23 Oct - Approved un-audited financial results for Q2 2024.
-
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
15 Oct - Intimation of Board meeting on financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Oct
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
Company does business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc., micronutrients, bio products, etc.